PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Jul-2022 Vaccentis appoints Martin Munte as CEO and strengthens Board Vaccentis
12-Jul-2022 Scottish Medicines Consortium issues interim acceptance to Novartis’ Adakveo®▼ (crizanlizumab) for preventing recurrent vaso-occlusive crises, the first treatment for sickle cell disorder in over 20 years Novartis
12-Jul-2022 Research shows investigational drug fosters nerve repair after injury University of Brimingham
12-Jul-2022 Pivotal data demonstrate once-weekly efanesoctocog alfa provides superior bleed protection compared to prior factor prophylaxis Global Newswire
12-Jul-2022 Phase 3 data for concizumab show 86% reduction in treated bleeds in haemophilia A or B with inhibitors Novo Nordisk
12-Jul-2022 No thromboembolic events or related serious adverse events reported over 12-week observation period in FRONTIER1 study. Novo Nordisk
12-Jul-2022 Kepler Vision Technologies launches international expansion with NESK partnership Kepler Vision Technologies
12-Jul-2022 DKSH and Pharmanovia Partner to Respond to Therapeutic Needs in Southeast Asia DKSH
12-Jul-2022 NAME HEATWAVES AS PART OF EARLY WARNING SYSTEM TO SAVE LIVES The Physiological Society
12-Jul-2022 HDR UK and Wellcome launch Biomedical Vacation Scholarship Programme 2022 HDR UK
12-Jul-2022 Endogena Therapeutics transitions into clinical stage with its novel regenerative treatment for blindness caused by retinitis pigmentosa Endogena Therapeutics
12-Jul-2022 ABB and Red Hat partner to deliver further scalable digital solutions across industrial edge and hybrid cloud ABB
12-Jul-2022 Yposkesi reinforces team with three executive appointments Andrew Lloyd Associates
12-Jul-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
12-Jul-2022 Neuraxpharm to increase branded business through upcoming acquisition of established products from Sanofi Neuraxpharm
12-Jul-2022 vasopharm GmbH Announces Brain Lactate Microdialysate Data from Post Hoc Analyses of Clinical Trials in Traumatic Brain Injury vasopharm GmbH
12-Jul-2022 Destiny Pharma receives award from the Cystic Fibrosis Foundation Destiny Pharma
12-Jul-2022 Anjarium Biosciences appoints experienced industry executives Samantha Vieira as Chief Operating Officer and Nate Massari as Chief Business Officer Anjarium Biosciences
12-Jul-2022 Genmab Major Shareholder Announcement Genmab
12-Jul-2022 No thromboembolic events or related serious adverse events reported over 12-week observation period in FRONTIER1 study.1 Novo Nordisk